Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Proof that taking some profits is a good thing.
Down 42% from the 52 week high. It's not a hard calculation.
So $8.96/share.
• Cash at 6/30/24 was $232.2M, a $44.9M decrease relative to 3/31/24.
Zero net debt. which I believe was part of LG's schtick a couple of years ago, would have also been positive for CLF's credit rating.
So you bought a fixed annuity with your retirement and are fretting about a small cap biotech. Nothing contradictory there.
They must have put some thought into how to manage a launch, unlike some companies (looking at you Revance).
Anyone know who the car company is that only buys cheap stuff?
"And because we are so big and supporting pretty much all of them except one that only buys cheap stuff" - LG
No Labor Agreement, No Deal: US Steel Union Draws Line for Nippon Merger
No Labor Agreement, No Deal: US Steel Union Draws Line for Nippon Merger
Don't be obtuse. 235 is obviously another ENTA flame out. Nobody wants it.
Are we running out of fat people?
Seems like your climate change guilt is forcing you to advocate for poverty. Not sure this is the right forum.
Why's it 25% off its 52 week high?
Funny you didn't mention the proximate beneficiary of student loans - the schools.
Someone should start an ETF that shorts biotech IPO's and reverse mergers.
seems scammy
Any thoughts on the home builders they also mention?
A 70k loan should not be permitted. This is predatory and abusive.
not staggering. not even impressive.
cash? not for much longer.
the bod should be shot.
longs bet on the wrong horse. abandon all hope.
that's an astonishing burn rate
There's a reason both political parties support CFIUS. There's also a reason why MNTA shit-canned their biosimilar spin out. CFIUS isn't it.
great short coming to market
Post of the year.
So you are saying that they purposely drug their feet to lose the Amgen deal, preferring no deal at all? That is a better plan? They had term sheets waiting in the wings I suppose, and multiple readouts due at any time, so stay tuned. These rationalizations of yours give me a headache.
Bayer's market cap will be a lot lower. glyphosphate could bankrupt them, no?
worst takeover ever.
Maybe. But you can't deny that ag/DE is cyclical.
What's the typical cyclical downside? 50%?
I do not, as a serious, thoughtful, experienced investor see anything other than bankruptcy in ADXS's future.
Face it, they aren't worrying about the stakeholders who are shareholders, at this point.
why? need to raise some cash to flush?
you suggest a presumption of dishonesty and yet you are still long?
hmmm.
The run up to $30 was a stupid gift. Glad I got out around $25.
Yes, poorly managed companies are targets of short sellers.
Yes, ADXS has been poorly managed for several years.
wow! amazing and frightening at the same time.
Who's we?
you are comparing a promising technology to a poorly run, under-capitalized company.
adxs is just the most recent of DD's failures.
goats
rvnc
etc
is roy a hired hack?
They can't raise a lot of money. The tiny market cap precludes a large raise.